Myovant Sciences Inc, based in Brisbane, CA, is dedicated to improving the health and well-being of people worldwide through innovative treatments in critical areas such as psychiatry, neurology, oncology, urology, women's health, rare diseases, and cell and gene therapy.
With a focus on driving faster and more efficient drug discovery and development, Myovant Sciences Inc, under the umbrella of Sumitomo Pharma America, is committed to fueling breakthroughs and delivering patient-first solutions through a technology-driven approach across diverse pipeline programs.
Generated from the website